Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation

References

• Kocbek P, Baumgartner S, Kristl J. (2006). Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int J Pharm, 312:179–186.
   PubMed Web of Science ®Google Scholar
• Zhang HX, Wang JX, Zhang ZB, Le Y, Shen ZG, Chen JF. (2009). Micronization of atorvastatin calcium by antisolvent precipitation process. Int J Pharm, 374:106–113.
   PubMed Web of Science ®Google Scholar
• Perrut M, Jung J, Leboeuf F. (2005). Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I: Micronization of neat particles. Int J Pharm, 288:3–10.
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun C, Hao Y, Jiang T, Zheng L, Wang S. (2010). Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles. J Pharm Pharm Sci, 13:589–606.
   PubMed Web of Science ®Google Scholar
• Yu L. (2001). Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv Drug Deliv Rev, 48:27–42.
   PubMed Web of Science ®Google Scholar
• Van Eerdenbrugh B, Van den Mooter G, Augustijns P. (2008). Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm, 364:64–75.
   PubMed Web of Science ®Google Scholar
• Kesisoglou F, Panmai S, Wu Y. (2007). Nanosizing–oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev, 59:631–644.
   PubMed Web of Science ®Google Scholar
• Liversidge GG, Conzentino P. (1995). Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int J Pharm, 125, 309–313.
   Web of Science ®Google Scholar
• Kumar V, Wang L, Riebe M, Tung HH, Prud’homme RK. (2009). Formulation and stability of itraconazole and odanacatib nanoparticles: governing physical parameters. Mol Pharm, 6:1118–1124.
   PubMed Web of Science ®Google Scholar
• Makhlof A, Miyazaki Y, Tozuka Y, Takeuchi H. (2008). Cyclodextrins as stabilizers for the preparation of drug nanocrystals by the emulsion solvent diffusion method. Int J Pharm, 357:280–285.
   PubMed Web of Science ®Google Scholar
• Matteucci ME, Hotze MA, Johnston KP, Williams RO3rd. (2006). Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir, 22:8951–8959.
   PubMed Web of Science ®Google Scholar
• Ruch F, Matijevic E. (2000). Preparation of Micrometer Size Budesonide Particles by Precipitation. J Colloid Interface Sci, 229:207–211.
   PubMed Web of Science ®Google Scholar
• Zhang JY, Shen ZG, Zhong J, Hu TT, Chen JF, Ma ZQ et al. (2006). Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants. Int J Pharm, 323:153–160.
   PubMed Web of Science ®Google Scholar
• Dhumal RS, Biradar SV, Yamamura S, Paradkar AR, York P. (2008). Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability. Eur J Pharm Biopharm, 70:109–115.
   PubMed Web of Science ®Google Scholar
• Guo Z, Zhang M, Li H, Wang J, Kougoulos E. (2005). Effect of ultrasound on anti-solvent crystallization process. J Cryst Growth, 273, 555–563.
   Web of Science ®Google Scholar
• Louhi-Kultanen M, Karjalainen M, Rantanen J, Huhtanen M, Kallas J. (2006). Crystallization of glycine with ultrasound. Int J Pharm, 320:23–29.
   PubMed Web of Science ®Google Scholar
• Luque De Castro MD, Priego-Capote F. (2007). Ultrasound-assisted crystallization (sonocrystallization). Ultrason Sonochem, 14, 717–724.
   PubMed Web of Science ®Google Scholar
• Löbenberg R, Amidon GL. (2000). Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm, 50:3–12.
   PubMed Web of Science ®Google Scholar
• Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G et al. (2004). Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm, 274:65–73.
   PubMed Web of Science ®Google Scholar
• Margulis-Goshen K, Magdassi S. (2009). Formation of simvastatin nanoparticles from microemulsion. Nanomedicine, 5:274–281.
   PubMed Web of Science ®Google Scholar
• Verma S, Gokhale R, Burgess DJ. (2009). A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int J Pharm, 380:216–222.
   PubMed Web of Science ®Google Scholar
• Lindfors L, Skantze P, Skantze U, Rasmusson M, Zackrisson A, Olsson U. (2006). Amorphous drug nanosuspensions. 1. Inhibition of Ostwald ripening. Langmuir, 22:906–910.
   PubMed Web of Science ®Google Scholar
• Lee J, Lee SJ, Choi JY, Yoo JY, Ahn CH. (2005). Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion. Eur J Pharm Sci, 24:441–449.
   PubMed Web of Science ®Google Scholar
• Dong Y, Ng WK, Shen S, Kim S, Tan RB. (2009). Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation. Int J Pharm, 375:84–88.
   PubMed Web of Science ®Google Scholar
• Raghavan SL, Trividic A, Davis AF, Hadgraft J. (2001). Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm, 212:213–221.
   PubMed Web of Science ®Google Scholar
• Xia D, Quan P, Piao H, Piao H, Sun S, Yin Y et al. (2010). Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci, 40:325–334.
   PubMed Web of Science ®Google Scholar
• Zimmermann A, Millqvist-Fureby A, Elema MR, Hansen T, Müllertz A, Hovgaard L. (2009). Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: effects on physicochemical properties. Eur J Pharm Biopharm, 71:109–116.
   PubMed Web of Science ®Google Scholar
• Sharma P, Denny WA, Garg S. (2009). Effect of wet milling process on the solid state of indomethacin and simvastatin. Int J Pharm, 380:40–48.
   PubMed Web of Science ®Google Scholar
• Müller RH, Benita S, Böhm BHL. Emulsions and nanosuspensions for the formulation of poorly soluble drugs. Stuttgart: Medpharm Scientific Publishers; 1998.
   Google Scholar
• Qiu Y, Chen Y, Zhang GGZ. Developing solid oral dosage forms: pharmaceutical theory and practice. Burlington: Academic; 2009.
   Google Scholar
• Ambike AA, Mahadik KR, Paradkar A. (2005). Spray-dried amorphous solid dispersions of simvastatin, a low tg drug: in vitro and in vivo evaluations. Pharm AQ4 m Res, 22:990–998.
   PubMed Web of Science ®Google Scholar
• Hintz RJ, Johnson KC. (1989). The effect of particle size distribution on dissolution rate and oral absorption. Int J Pharm, 51, 9–17.
   Web of Science ®Google Scholar
• Jia L, Wong H, Cerna C, Weitman SD. (2002). Effect of nanonization on absorption of 301029: ex vivo and in vivo pharmacokinetic correlations determined by liquid chromatography/mass spectrometry. Pharm Res, 19:1091–1096.
   PubMed Web of Science ®Google Scholar